The current valuation score of Standard BioTools Inc is 7.10, ranking 173 out of 204 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 3.77, which is 68.66% below the recent high of 6.35 and 258.25% above the recent low of -5.96.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.